Fenofibrate (INN), marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates, it aims to reduce both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing triglyceride levels. It is used alone or along with statins in the treatment of hypercholesterolemia and hypertriglyceridemia. Fenofibrate has been used since 1975, is one of the most commonly prescribed fibrates.
On Dec, 29, 2016 18,130 people reported to have side effects when taking Tricor.
Among them, 279 people (1.54%) have Death
Time on Tricor when people have Death :
|
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
Death |
0.00% |
0.00% |
16.67% |
0.00% |
50.00% |
0.00% |
33.33% |
On Dec, 16, 2016 18,130 people reported to have side effects when taking Tricor.
Among them, 131 people (0.72%) have Hallucination
Time on Tricor when people have Hallucination :
|
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
Hallucination |
60.00% |
0.00% |
20.00% |
0.00% |
20.00% |
0.00% |
0.00% |
Gender of people who have Hallucination when taking Tricor :
|
Female |
Male |
Hallucination |
52.21% |
47.79% |
Age of people who have Hallucination when taking Tricor :
|
0-1 |
2-9 |
10-19 |
20-29 |
30-39 |
40-49 |
50-59 |
60+ |
Hallucination |
0.00% |
0.00% |
1.18% |
0.00% |
2.35% |
16.47% |
27.06% |
52.94% |